Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diabetes in 2005].

Serge Halimi1

  • 1Département DUNE Département d'Uro Néphro-Endocrinologie), CHU de Grenoble, 11A, BP217X Grenoble 09, France. SHalimi@chu-grenoble.fr

Nephrologie & Therapeutique
|March 24, 2007
PubMed
Summary
This summary is machine-generated.

Diabetes is a growing global health crisis, particularly in developing nations, driven by lifestyle changes and poor diets. Early and aggressive treatment, alongside lifestyle modification, is crucial for managing diabetes and its associated risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairment.

Diabetes, obesity & metabolism·2018
Same author

Cardiovascular Complications Over 5 Years and Their Association With Survival in the GERODIAB Cohort of Elderly French Patients With Type 2 Diabetes.

Diabetes care·2017
Same author

Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study.

Annales d'endocrinologie·2016
Same author

New Insulin Delivery Recommendations.

Mayo Clinic proceedings·2016
Same author

Simple calculator to estimate the medical cost of diabetes in sub-Saharan Africa.

World journal of diabetes·2015
Same author

Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database.

Vascular health and risk management·2015
Same journal

Supporting patients and family members facing treatment choices in chronic kidney disease: What do professionals think of the decision aids used? - Professionals’ views on treatment decision support tools

Nephrologie & therapeutique·2026
Same journal

From Turing to ChatGPT: The origins and transformations of medical artificial intelligence

Nephrologie & therapeutique·2026
Same journal

Analysis of the predictive value of serum Cys-C and IL-6 levels for acute kidney injury in patients with acute respiratory distress syndrome.

Nephrologie & therapeutique·2026
Same journal

Navigating pain in chronic kidney disease: Overcoming inertia!

Nephrologie & therapeutique·2026
Same journal

Kidney health for all: caring for people, protecting the planet1.

Nephrologie & therapeutique·2026
Same journal

When the heart breaks, the kidneys follow: A case of Takotsubo syndrome

Nephrologie & therapeutique·2026
See all related articles

Area of Science:

  • Endocrinology
  • Public Health
  • Metabolic Syndrome

Context:

  • Diabetes mellitus incidence has tripled globally since 1985, escalating into a major public health concern.
  • Developing countries face alarming diabetes prevalence rates, surpassing those in developed nations, linked to dietary shifts and increased Body Mass Index (BMI).
  • Decreased physical activity and modern lifestyles contribute significantly to the rise of diabetes and associated metabolic dysfunctions.

Purpose:

  • To highlight the escalating global prevalence of diabetes and its associated health risks.
  • To underscore the impact of lifestyle factors, including diet and physical activity, on diabetes development.
  • To emphasize the evolving treatment paradigms for diabetes, advocating for earlier and more intensive management strategies.

Summary:

Related Experiment Videos

  • Type 2 diabetes is closely linked to metabolic syndrome components, increasing risks of hypertension, dyslipidemias, cardiovascular, and renal diseases.
  • Lifestyle changes, such as improved diet and increased physical activity, are vital for diabetes prevention worldwide.
  • Current diabetes treatment emphasizes aggressive control of glycemia, blood pressure, and lipids, supported by new pharmaceutical interventions and robust clinical trial evidence.

Impact:

  • This research underscores the urgent need for global public health interventions to combat the diabetes epidemic.
  • The findings support the "treat earlier and stronger" approach in diabetes management to mitigate severe health complications.
  • Evidence-based strategies and new drug availability offer a promising outlook for more effective diabetes control and prevention.